Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 5, 2002

View Archived Issues

Promising early clinical results for dexosome vaccine in melanoma

Clinical data on the proteasome inhibitor PS-341 in multiple myeloma updated

Influence of renal dysfunction on safety profile of pemetrexed

Pharmacokinetics of epothilone B assessed in patients with advanced cancer

Tadalafil reported safe and effective in broad-spectrum erectile dysfunction

No beneficial effects found for nutritional supplementation in fibromyalgia

Preliminary data suggest potential for pramipexole in fibromyalgia

Potential use of pregabalin in fibromyalgia

Novel mu-selective opioid ligand identified at Purdue Pharma

Dyax and Thios enter therapeutic antibody discovery and development collaboration

Chemokine CCR2 and/or CCR3 antagonists under study at Pfizer

Ferring and Johnson & Johnson to develop new generation of type 2 diabetes drugs

NeuroSearch claims modulators of monoamine receptors and transporters with broad applications

Prodrug-based antiinfectives objective of Ricerca and ProQuest collaboration

Novel HIV reverse transcriptase inhibitors in Medivir pipeline

Pharmacia researchers describe new CDK inhibitors for cancer and other indications

Progen receives clearance to begin PI-166 clinical trial

Servier and ConjuChem report novel albumin-binding metalloproteinase inhibitors

Serono and Ivax to develop and commercialize oral cladribine for MS

Novartis to sell Leucomax rights to Schering-Plough

Oryx to market Angiomax in Canada

Replagal E.U. labeling expanded to include treatment of females

Potential for OPC-14523 in bulimia nervosa and OCD

Novel mglu5 receptor antagonists as potential anxiolytic agents

Anxiolytic profile of PNU-57378E evaluated in rodent models

Novartis acquires rights to AGE breaker from Torrent

SuperGen to begin Orathecin NDA submission by year-end 2002

Biovail receives tentative FDA approval for Flash Dose zolpidem

Pravachol approved for use in pediatric patients

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...